How Boehringer Ingelheim is buttressing its US business
With a new president of U.S. | In this episode of the "Top Line," we dive into Boehringer Ingelheim’s latest regulatory successes, two crucial launches, and the German company’s expanding commercialization focus in the U.S.
With a new president of U.S. | In this episode of the "Top Line," we dive into Boehringer Ingelheim’s latest regulatory successes, two crucial launches, and the German company’s expanding commercialization focus in the U.S.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
